Leucadia National Corp acquired a new stake in UnitedHealth Group (NYSE:UNH) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,170 shares of the healthcare conglomerate’s stock, valued at approximately $478,000.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Maverick Capital Ltd. purchased a new stake in UnitedHealth Group in the second quarter valued at approximately $4,048,000. Kingdon Capital Management L.L.C. purchased a new stake in UnitedHealth Group in the second quarter valued at approximately $13,841,000. Arrowstreet Capital Limited Partnership raised its position in UnitedHealth Group by 30.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,303,068 shares of the healthcare conglomerate’s stock valued at $241,615,000 after purchasing an additional 300,744 shares during the period. Tower Research Capital LLC TRC raised its position in UnitedHealth Group by 3,881.4% in the second quarter. Tower Research Capital LLC TRC now owns 6,211 shares of the healthcare conglomerate’s stock valued at $1,152,000 after purchasing an additional 6,055 shares during the period. Finally, Coldstream Capital Management Inc. raised its position in UnitedHealth Group by 37.8% in the second quarter. Coldstream Capital Management Inc. now owns 1,698 shares of the healthcare conglomerate’s stock valued at $315,000 after purchasing an additional 466 shares during the period. Hedge funds and other institutional investors own 86.80% of the company’s stock.
A number of analysts have issued reports on UNH shares. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, December 27th. Evercore ISI reissued an “outperform” rating and issued a $255.00 target price (up previously from $235.00) on shares of UnitedHealth Group in a research report on Friday, January 12th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price on the stock in a research report on Saturday, January 20th. Goldman Sachs started coverage on UnitedHealth Group in a research report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 target price on the stock. Finally, Cantor Fitzgerald boosted their target price on UnitedHealth Group to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, January 17th. Three analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and an average target price of $244.62.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. UnitedHealth Group’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.11 earnings per share. analysts predict that UnitedHealth Group will post 12.52 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 20th. Investors of record on Friday, March 9th were issued a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.34%. The ex-dividend date was Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 29.79%.
In related news, Director William C. Ballard, Jr. sold 10,000 shares of the stock in a transaction on Tuesday, January 23rd. The stock was sold at an average price of $246.38, for a total value of $2,463,800.00. Following the transaction, the director now owns 76,637 shares of the company’s stock, valued at $18,881,824.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Larry C. Renfro sold 22,184 shares of the stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $228.94, for a total value of $5,078,804.96. Following the completion of the transaction, the insider now directly owns 173,229 shares in the company, valued at approximately $39,659,047.26. The disclosure for this sale can be found here. Insiders sold 77,015 shares of company stock worth $17,879,199 in the last three months. 0.89% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY WARNING: This story was first reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.chaffeybreeze.com/2018/04/16/leucadia-national-corp-takes-478000-position-in-unitedhealth-group-unh.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.